Professional
Added to YB: 2024-11-18
Pitch date: 2024-10-31
LFCR [bullish]
Lifecore Biomedical, Inc.
+10.76%
current return
Author Info
Greenhaven Road is a boutique hedge fund with the patience and confidence to step outside of the norm. Visit their website.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$237.1M
Pitch Price
$5.76
Price Target
28.40 (+345%)
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
growth
Greenhaven Road Capital Portfolio Holding: Lifecore Biomedical, Inc.
LFCR: CDMO for sterile injectables. New CEO/CFO, doubled capacity (35% utilization). 12%+ revenue growth expected. Margins to improve from 15% to 25-30%. Trading at <15x EV/EBITDA vs recent acquisitions at >25x. Risks: execution, near-term growth flat. Potential 2-5x return in medium term.
Read full article (4 min)